Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI

Neurology

Volumn 52, Issue 3, 1999, Pages 588-594

  Filippi, Massimo ^b   Iannucci, G ^c   Tortorella, C ^c   Minicucci, L ^c   Horsfield, M A ^c   Colombo, B ^c   Sormani, M P ^a   Comi, G ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN SCINTISCANNING; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0033021883     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.588     Document Type: Article

References (38)

1. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 1995;118: 1601-1612.
2. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
3. Filippi M, Horsfield MA, Ader HI, et al. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 1998;43:449-506.
4. Thompson AJ, Kermode AG, MacManus DG, et al. Pattern of disease activity: clinical and magnetic resonance imaging study. BMJ 1990;300:631-634.
5. Thompson AJ, Miller D, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing-remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63.
6. Filippi M, Campi A, Mammi S, et al. Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;58:31-37.
7. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
8. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-1096.
9. Filippi M, Campi A, Martinelli V, et al. A brain MRI study of different types of chronic-progressive multiple sclerosis. Acta Neurol Scand 1995;91:231-233.
10. Lycklama à Nijeholt GJ, van Walderveen MAA, Castelijins JA, et al. Brain and spinal cord abnormalities in multiple sclerosis: Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-697.
11. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-334.
12. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-274.
13. Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793.
14. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338:278-285.
15. Filippi M, Miller DH. MRI in the differential diagnosis and monitoring the treatment of multiple sclerosis. Curr Opin Neurol 1996;9:176-186.
16. Barbosa S, Blumhardt LD, Roberts N, Lock T, Edwards RHT. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the 'invisible' lesion load. Magn Reson Imaging 1994;12:33-42.
17. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482.
18. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;96:511-515.
19. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-391.
20. Fu L, Matthews PM, De Stefano N, et al. Imaging of axonal damage of normal appearing white matter in multiple sclerosis. Brain 1998;121:103-113.
21. van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288.
22. 1-weighted) spin-echo images. Neurology 1995;45:1684-1690.
23. 1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476.
24. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994;36:S97-S99.
25. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-67.
26. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636.
27. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
28. Lublin FD, Reingold SC for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
29. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
30. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991;54:683-688.
31. Grimaud J, Lai M, Thorpe JW, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996;14: 495-505.
32. 2-weighted images. J Neurol 1997;244:266-270.
33. 1 SE in MS. Proceedings of the International Society for Magnetic Resonance in Medicine 1998;2: 1334.
34. Morrisey SP, Miller DH, Kendall BE, et al. The significance of brain magnetic resonance imaging abnormalities at presentation with a clinically isolated syndrome suggestive of multiple sclerosis: a 5-year follow-up study. Brain 1993;116:135-146.
35. Filippi M, Horsfield MA, Morrisey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndrome suggestive of multiple sclerosis. Neurology 1994;44: 635-641.
36. Barkhof F, Filippi M, Miller D, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-2069.
37. O'Riordan JI, Thompson AJ, Kingsley DPE, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS: a 10-year follow-up. Brain 1998;121:495-503.
38. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesion and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:736-742.